Interleukin-17 in pancreatic cancer recruits neutrophils, triggers neutrophil extracellular traps (NETs), and excludes cytotoxic CD8 T cells from the tumor, reducing the sensitivity of immune checkpoint blockade (PD-1, CTLA4) (62). This evidence concerns the gene PDCD1 and neoplasm.